MARKET

BLFS

BLFS

BioLife
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.25
+0.15
+0.57%
After Hours: 25.50 -0.75 -2.86% 17:44 09/25 EDT
OPEN
26.22
PREV CLOSE
26.10
HIGH
26.58
LOW
25.20
VOLUME
351.59K
TURNOVER
--
52 WEEK HIGH
28.28
52 WEEK LOW
7.37
MARKET CAP
840.04M
P/E (TTM)
197.67
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
BioLife Solutions downgraded to perform from outperform at Oppenheimer
BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
marketwatch.com · 4d ago
BioLife Solutions to acquire SciSafe for $30M cash and stock deal
BioLife Solutions (BLFS) to acquire SciSafe, a privately held multi-facility provider of biological materials storage to the cell and gene therapy and pharmaceutical industries for $15M in cash and $15M
Seekingalpha · 5d ago
BioLife Solutions To Acquire SciSafe For $15M In Cash And $15M In Newly Issued Shares
BOTHELL, Wash., Sept. 21, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS)("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining
Benzinga · 5d ago
BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced it has entered into a definitive agreement to acquire SciSafe, a privately held multi-facility
PR Newswire · 5d ago
BioLife Solutions initiated Buy at Cowen; indicates stock significantly undervalued
BioLife Solutions ([[BLFS]] +5.2%) initiated at Cowen with Outperform, PT $33, indicating the stock is significantly undervalued; currently hovering around 52-week high levels gained 166% in past 6 months trading.Wall Street
Seekingalpha · 09/18 17:25
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)
Benzinga · 09/17 11:59
Do Its Financials Have Any Role To Play In Driving BioLife Solutions, Inc.'s (NASDAQ:BLFS) Stock Up Recently?
Most readers would already be aware that BioLife Solutions' (NASDAQ:BLFS) stock increased significantly by 37% over...
Simply Wall St. · 09/08 12:45
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)
Benzinga · 09/03 11:55
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BLFS. Analyze the recent business situations of BioLife through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BLFS stock price target is 32.83 with a high estimate of 35.00 and a low estimate of 30.00.
EPS
Institutional Holdings
Institutions: 113
Institutional Holdings: 16.46M
% Owned: 51.44%
Shares Outstanding: 32.00M
TypeInstitutionsShares
Increased
31
3.33M
New
25
134.61K
Decreased
17
654.33K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.16%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Independent Director
Raymond Cohen
President/Chief Executive Officer/Director
Michael Rice
Chief Financial Officer/Chief Operating Officer/Secretary/IR Contact Officer
Roderick de Greef
Executive Vice President/Chief Scientific Officer
Aby Mathew
Chief Marketing Officer
Todd Berard
Vice President/Director of Sales
Marcus Schulz
Other
Karen Foster
Director
Thomas Girschweiler
Independent Director
Andrew Hinson
Independent Director
Joseph Schick
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BLFS
BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BioLife Solutions Inc stock information, including NASDAQ:BLFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLFS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLFS stock methods without spending real money on the virtual paper trading platform.